Thrombosis News and Research

Latest Thrombosis News and Research

What is the impact of monkeypox infection on the hemostatic system?

In a recent study, researchers determined if monkeypox (MPX) infection affected the hemostatic system like that observed in coronavirus disease 2019 (COVID-19).

6 Oct 2022

People with developmental disability at high risk of avoidable in-hospital safety incidents

People with developmental disability are nearly three times as likely than other patients to experience preventable physical injuries while in hospital, reveals new research by the London School of Economics and Political Science (LSE) and the Universitat de Barcelona.

3 Oct 2022

Research may lead to safer ways to care for patients impacted by blood clots

A nanoparticle therapy developed by investigators at University Hospitals (UH) and Case Western Reserve University targets overactive neutrophils, a specific kind of white blood cell, to prevent almost all types of blood clots while causing no increased risk for bleeding.

30 Sep 2022

Epileptic seizures are more common after cerebral venous thrombosis

Epileptic seizures are frequent among patients with cerebral venous thrombosis — a blood clot affecting the venous system of the brain.

30 Sep 2022

How the gut microbiome could affect COVID-19 severity

Researchers review the potential role of the gut microbiome in determining severe COVID-19.

27 Sep 2022

Association of self-reported chronic fatigue and retinal microcirculation in post-COVID-19 syndrome patients

Researchers investigated the potential association between self-reported chronic fatigue and retinal microcirculation among post-COVID-19 syndrome patients.

27 Sep 2022

Researchers explore neurological manifestations among long COVID patients

In a new study, researchers assessed the long-term neurological sequelae in the post-acute phase of coronavirus disease 2019 (COVID-19) or long COVD.

26 Sep 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

Population-wide cohort study detects increase in major arterial and venous thrombotic events immediately after COVID-19 diagnoses

In a new study, researchers explored the association between coronavirus disease 2019 (COVID-19) and vascular thrombotic events using a population-wide cohort study across England and Wales.

21 Sep 2022

Study: Life-threatening blood clots remain for at least 49 weeks after COVID-19

COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.

21 Sep 2022

Combined oral contraceptives associated with elevated risk of venous thromboembolism in obese women

Obese women who use oral contraceptives containing estrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to a review paper published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).

14 Sep 2022

Study investigates the prevalence of adrenal tumors in an unselected screening population

A cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an unselected community population was 1.4%. The prevalence increased with age, from 0.2% in adults aged 18 to 25 up to 3.2% in adults older than 65 years of age. However, approximately 70% of identified tumors were nonfunctioning, meaning they did not make extra hormones, regardless of the participant's age. The findings are published in Annals of Internal Medicine.

13 Sep 2022

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related complications after surgery, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.

12 Sep 2022

Review explores the involvement of the endothelium as an important underpinning of long COVID’s pathophysiology

Researchers discussed possible mechanisms and potential treatment methods for endotheliopathy observed in patients with post-acute sequelae of SARS-CoV-2 infection.

6 Sep 2022

Study suggests strategies to bolster the administration of clot-busting drugs

Venous thromboembolism (VTE) is a potentially deadly condition in which a blood clot (known as a deep vein thrombosis [DVT]) forms in the deep veins of the leg, groin or arm and may dislodge.

1 Sep 2022

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

A heart check-up is recommended in even apparently healthy people over 65 years of age before intermediate- or high-risk non-cardiac surgery, according to European Society of Cardiology (ESC) Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery published online today in European Heart Journal.

26 Aug 2022

CU professor explores for noninvasive ways to detect vascularized composite allograft rejection

Soldiers and others who receive severe injuries to the hands and face often can benefit from a type of transplant known as vascularized composite allograft (VCA) -; the transplantation of multiple tissues, including muscle, bone, nerve, skin, and blood vessels, as a functional unit (such as a hand or face) from a deceased donor to a recipient with a severe injury.

25 Aug 2022

Thrombosis News and Research

Latest Thrombosis News and Research

What is the impact of monkeypox infection on the hemostatic system?

People with developmental disability at high risk of avoidable in-hospital safety incidents

Research may lead to safer ways to care for patients impacted by blood clots

Epileptic seizures are more common after cerebral venous thrombosis

How the gut microbiome could affect COVID-19 severity

Association of self-reported chronic fatigue and retinal microcirculation in post-COVID-19 syndrome patients

Researchers explore neurological manifestations among long COVID patients

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

Population-wide cohort study detects increase in major arterial and venous thrombotic events immediately after COVID-19 diagnoses

Study: Life-threatening blood clots remain for at least 49 weeks after COVID-19

Combined oral contraceptives associated with elevated risk of venous thromboembolism in obese women

Study investigates the prevalence of adrenal tumors in an unselected screening population

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

Review explores the involvement of the endothelium as an important underpinning of long COVID’s pathophysiology

Study suggests strategies to bolster the administration of clot-busting drugs

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

CU professor explores for noninvasive ways to detect vascularized composite allograft rejection

Severe COVID-19 increases risk of future cardiovascular events

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

RCSI research provides greater insight into the causes of Long COVID syndrome

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Thrombosis News and Research

Latest Thrombosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in